← Browse by Condition
Medical Condition
end stage renal disease esrd
Total Trials
3
Recruiting Now
3
Trial Phases
Phase 4
ClinicalMetric tracks all active clinical trials for end stage renal disease esrd sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.
- Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
- Phase 1–4 studies from early safety trials to post-marketing surveillance
- NIH, pharmaceutical sponsor, and academic medical center studies worldwide
- AI-powered plain-language summary available for every trial listing
Trial Phases
Phase 4 1
Top Sponsors
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT07291154
Recruiting
Impact of APP-assisted Patient Management on the Quality Control of Blood Purification Therapy
Enrollment
392 pts
Location
China
Sponsor
Yunfeng Xia
NCT07146854
Recruiting
EndoForce Post Approval Study
Enrollment
150 pts
Location
United States
Sponsor
Phraxis, Inc.
NCT06597201 Phase 4
Recruiting
Evaluate the Efficacy and Safety of Amino Acid (15) Peritoneal Dialysis Solution in Peritoneal Dialysis Patients with Malnutrition.
Enrollment
400 pts
Location
China
Sponsor
Chengdu Qingshan Likang Pharma...
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology